Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001785982-20-000621
Filing Date
2020-07-16
Accepted
2020-07-16 17:29:18
Documents
1
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 sf0008h_form3.html 3  
1 sf0008h_form3.xml 3 2083
  Complete submission text file 0001785982-20-000621.txt   3786
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Issuer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BIOXYTRAN, INC 233 NEEDHAM ST., SUITE 300 NEWTON MA 02464
Business Address
Utter Anders (Reporting) CIK: 0001818430 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35027 | Film No.: 201032190